Stock priced under ₹20 has surged by 20% to hit the upper circuit after announcing a remarkable 1,235% year-over-year increase in net profits.
Stock under ₹20: The shares of Julien Agro Infratech Limited, a company specializing in infrastructure solutions for the agriculture and agro-processing industries, surged by 20 percent following the announcement of their Q3 results, which showed a remarkable 1,235 percent increase in profits year over year.
Market Performance
On Thursday, Julien Agro Infratech Limited, with a market capitalization of Rs. 47.6 crores, saw its shares reach a high of Rs. 12.03 per share, a 20 percent increase from the previous closing price of Rs. 10.03 per share.
Financial Results
The company reported impressive financial results for Q3FY25, with a 607 percent year-over-year growth in revenue from operations, reaching Rs. 38.63 crores. Additionally, net profit soared by 1,235 percent year over year, totaling Rs. 2.67 crores.
Corporate Actions
Julien Agro Infratech Limited also announced plans for fund raising through a preferential issue of 2,00,00,000 fully convertible equity warrants. Furthermore, the company declared a second interim dividend of Rs. 0.05 per equity share for the financial year 2024-25, with the Record Date set for Friday, February 07, 2025.
Recent Developments
In addition to these financial milestones, the company recently announced a stock split, with the Record Date scheduled for Wednesday, January 08, 2025. This split will sub-divide existing Equity Shares, with each fully paid-up share of Rs. 10 being split into two shares of Rs. 5 in a 1:2 ratio.
For more market insights, follow our blog.
Stay tuned for more updates and insights on the stock market! For more insights on investing in the Indian stock market, check out resource like ET, NSE India.
Disclaimer: This blog post is for informational purposes only and should not be considered financial advice. Investors should conduct thorough research and consult with a qualified financial advisor before making any investment decisions.